Aydan Eroglu

Aydan Eroglu

Auto-generated profile, based on publicly available information

Aydan Eroglu

Surgical Oncology Unit, Department of General Surgery, Ankara University School of Medicine, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2020 in European Journal of Breast Health
Verified
Journal Article
Closed access
OCOmer Arda Cetinkaya
Omer Arda Cetinkaya
SCSuleyman Utku Celik
Suleyman Utku Celik
STSerdar Gokay Terzioglu
Serdar Gokay Terzioglu
AEAydan Eroglu
Aydan Eroglu
Granulomatous mastitis,neutrophils,platelets,ratios


1 July 2022 in Phoenix Medical Journal
Verified
Journal Article
Open access
ŞDŞeref Dokcu
Şeref Dokcu
MÇMehmet Ali Çaparlar
Mehmet Ali Çaparlar
ÖÇÖzhan Çeti̇ndağ
Özhan Çeti̇ndağ
MHMusluh Hakseven
Musluh Hakseven
AEAydan Eroğlu
Aydan Eroğlu
Objective Breast cancer is a heterogeneous disease group that exhibits quite different biological behaviors and bear many genomic traces. Its dependence on sex hormones also determines its relationship with menopausal status. It is divided into five molecular subtypes according to receptor analysis and Ki67 level with immunohistochemical (IHC) markers. This study aimed to examine the relationship between the menopausal status and these molecular subtypes to help determine our treatment strategies. Material and Method The database of 250 patients who were operated on for breast cancer in our Oncology Clinic between 2012 and 2020 was retrospectively analyzed. The patients were grouped by their menopausal status and clinicopathological characteristics. Statistical analysis was made at a 95% confidence interval, and a p-value lower than 0.05 was considered statistically significant. Results The patients were divided into 2 groups by their menopausal status as 44.8% (n = 112) as premenopausal and 65.2% (n=138) as postmenopausal. In the statistical analysis performed, the level of Ki67 was high in premenopausal women (p=0.015). Also, tumors seen in premenopausal women were associated with ER negativity (p=0.024) and high histological grade (grade3) (p=0.015). It was found that luminal subtype (luminal A, luminal B) breast cancers were observed more frequently in postmenopausal women and non-luminal subtypes (HER2+, TNBC) were observed more frequently in premenopausal women. Conclusion The genomic complexity that will determine personalized treatment strategies soon remains to be clarified. There is still a need for randomized, prospective, multidisciplinary, and population-based studies to help us understand this unknown nature.